Your browser doesn't support javascript.
loading
Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Ayau, Pedro; Bardossy, Ana C; Sanchez, Guillermo; Ortiz, Ricardo; Moreno, Daniela; Hartman, Pamela; Rizvi, Khulood; Prentiss, Tyler C; Perri, Mary B; Mahan, Meredith; Huang, Vanthida; Reyes, Katherine; Zervos, Marcus J.
Afiliação
  • Ayau P; Universidad Francisco Marroquin, Guatemala City, Guatemala.
  • Bardossy AC; Henry Ford Health System, Detroit, Michigan, USA.
  • Sanchez G; Universidad Francisco Marroquin, Guatemala City, Guatemala.
  • Ortiz R; Universidad Francisco Marroquin, Guatemala City, Guatemala.
  • Moreno D; Henry Ford Health System, Detroit, Michigan, USA.
  • Hartman P; Henry Ford Health System, Detroit, Michigan, USA.
  • Rizvi K; Henry Ford Health System, Detroit, Michigan, USA.
  • Prentiss TC; Henry Ford Health System, Detroit, Michigan, USA.
  • Perri MB; Henry Ford Health System, Detroit, Michigan, USA.
  • Mahan M; Henry Ford Health System, Detroit, Michigan, USA.
  • Huang V; Midwestern University College of Pharmacy-Glendale, Glendale, Arizona, USA.
  • Reyes K; Henry Ford Health System, Detroit, Michigan, USA.
  • Zervos MJ; Henry Ford Health System, Detroit, Michigan, USA; Wayne State University School of Medicine, Detroit, Michigan, USA.
Int J Infect Dis ; 61: 3-6, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28533166
ABSTRACT

OBJECTIVES:

Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections (BSI) are a major health care problem accounting for a large percentage of nosocomial infections. The aim of this study was to identify risk factors associated with 30-day mortality in patients with MRSA BSI.

METHODS:

This was a retrospective study performed in Southeast Michigan. Over a 9- year period, a total of 1,168 patients were identified with MRSA BSI. Patient demographics and clinical data were retrieved and evaluated using electronic medical health records.

RESULTS:

30-day mortality during the 9-year study period was 16%. Significant risk factors for 30-day mortality were age, cancer, heart disease, neurologic disease, nursing home residence and Charlson score >3 with Odds Ratio (OR) of 1.03 (CI 1.02-1.04), 2.29 (CI 1.40-3.75), 1.78 (CI 1.20-2.63), 1.65 (CI 1.08-2.25), 1.66 (CI 1.02 - 2.70) and 1.86 (CI 1.18 - 2.95) correspondingly. Diabetes mellitus, peripheral vascular disease (PVD), and readmission were protective factors for 30-day mortality with OR of 0.53 (CI 0.36-0.78), 0.46 (CI 0.26-0.84) and 0.13 (CI0.05 - 0.32) respectively.

CONCLUSIONS:

Our study identified significant risk factors for 30-day mortality in patients with MRSA BSI. Interestingly, diabetes mellitus, PVD and readmission were protective effects on 30-day mortality. There was no statistically significant variability in 30-day mortality over the 9-year study period.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Bacteriemia / Staphylococcus aureus Resistente à Meticilina Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Bacteriemia / Staphylococcus aureus Resistente à Meticilina Idioma: En Ano de publicação: 2017 Tipo de documento: Article